1.96
Schlusskurs vom Vortag:
$1.98
Offen:
$1.98
24-Stunden-Volumen:
369.89K
Relative Volume:
0.37
Marktkapitalisierung:
$239.78M
Einnahmen:
$34.16M
Nettoeinkommen (Verlust:
$-50.62M
KGV:
-3.8583
EPS:
-0.508
Netto-Cashflow:
$703.00K
1W Leistung:
-4.85%
1M Leistung:
+15.29%
6M Leistung:
-38.94%
1J Leistung:
-58.91%
Omniab Inc Stock (OABI) Company Profile
Firmenname
Omniab Inc
Sektor
Branche
Telefon
510-250-7800
Adresse
5980 HORTON STREET, EMERYVILLE
Vergleichen Sie OABI mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
OABI
Omniab Inc
|
1.96 | 252.01M | 34.16M | -50.62M | 703.00K | -0.508 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
572.71 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
2023-04-21 | Eingeleitet | The Benchmark Company | Buy |
2023-04-13 | Eingeleitet | Craig Hallum | Buy |
2023-02-22 | Eingeleitet | Cowen | Outperform |
2023-02-13 | Eingeleitet | H.C. Wainwright | Buy |
2022-12-20 | Eingeleitet | Truist | Buy |
2022-12-16 | Eingeleitet | Credit Suisse | Outperform |
2022-11-29 | Eingeleitet | SVB Leerink | Outperform |
2022-11-28 | Eingeleitet | Stifel | Buy |
Alle ansehen
Omniab Inc Aktie (OABI) Neueste Nachrichten
OmniAb to Report Second Quarter 2025 Financial Results on August 6 - BioSpace
Why OmniAb Inc. stock attracts strong analyst attentionInvestor Favorite Picks - Newser
What makes OmniAb Inc. stock price move sharplyFree Top Growth Stock Recommendations - Newser
Why OmniAb Inc. Equity Warrant stock attracts strong analyst attentionHigh Confidence Trade Setups - Newser
What makes OmniAb Inc. Equity Warrant stock price move sharplyShort Squeeze Radar - Newser
How OmniAb Inc. Equity Warrant stock performs during market volatilityShort Term Risk Controlled Alerts - Newser
How OmniAb Inc. stock performs during market volatilityLong Term Low Risk Growth - Newser
Market Participants Recognise OmniAb, Inc.'s (NASDAQ:OABI) Revenues Pushing Shares 38% Higher - simplywall.st
Is OmniAb, Inc. overvalued or undervalued? - MarketsMojo
OmniAb Elects Directors at Annual Shareholder Meeting - TipRanks
OmniAb shareholders elect two directors at annual meeting - Investing.com
OmniAb Inc Inc. (OABI) Price Performance: A Fundamental Analysis Perspective - investchronicle.com
OmniAb Stock Soars: Is It Time to Buy? - StocksToTrade
OmniAb, Inc. (NASDAQ:OABI) Shares Acquired by Squarepoint Ops LLC - Defense World
Millennium Management LLC Buys 61,993 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
June 2025's Promising Penny Stocks to Consider - Yahoo Finance
OmniAb, Inc. (NASDAQ:OABI) Stake Cut by Jane Street Group LLC - Defense World
AI Is Rewiring Healthcare Faster Than Expected — Investors Are Hunting for Public Winners Now - The Globe and Mail
Delek Logistics Partners, LP Increases Quarterly Cash Distribution to $1.025 per Common Limited Partner Unit - The Globe and Mail
OmniAb, Inc. (NASDAQ:OABI) Shares Purchased by ProShare Advisors LLC - Defense World
BNP Paribas Financial Markets Buys Shares of 17,549 OmniAb, Inc. (NASDAQ:OABI) - Defense World
Bank of America Corp DE Has $2.18 Million Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OABI stock touches 52-week low at $1.25 amid market challenges - Investing.com Australia
OABI stock touches 52-week low at $1.25 amid market challenges By Investing.com - Investing.com South Africa
Northern Trust Corp Acquires 45,169 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
Deutsche Bank AG Increases Stake in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Deal Watch: QurAlis Targets Fragile-X Syndrome In Deals With Quiver, UMass - insights.citeline.com
OmniAb’s SWOT analysis: antibody discovery firm’s stock faces growth opportunities amid market challenges - Investing.com Canada
OmniAb Inc (NASDAQ: OABI) Could Pass $4 In One Year Stock Forecast - Stocksregister
Insider Spends US$94k Buying More Shares In OmniAb - simplywall.st
Chairman of OmniAb Picks Up 3.0% More Stock - Yahoo Finance
51,159 Shares in OmniAb, Inc. (NASDAQ:OABI) Purchased by Balyasny Asset Management L.P. - Defense World
Price T Rowe Associates Inc. MD Has $136,000 Stock Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Leerink Partnrs Has Bullish Forecast for OmniAb Q2 Earnings - Defense World
Insider Buying: Jennifer Cochran Acquires 30,000 Shares of OmniA - GuruFocus
Finanzdaten der Omniab Inc-Aktie (OABI)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):